vs

Side-by-side financial comparison of Invesco (IVZ) and Rollins, Inc. (ROL). Click either name above to swap in a different company.

Invesco is the larger business by last-quarter revenue ($1.7B vs $906.4M, roughly 1.9× Rollins, Inc.). Rollins, Inc. runs the higher net margin — 11.9% vs -58.9%, a 70.8% gap on every dollar of revenue. On growth, Rollins, Inc. posted the faster year-over-year revenue change (10.2% vs 6.2%). Invesco produced more free cash flow last quarter ($432.2M vs $111.2M). Over the past eight quarters, Invesco's revenue compounded faster (7.1% CAGR vs 0.8%).

Invesco Ltd. is an American independent investment management company headquartered in Atlanta, Georgia, with branch offices in 20 countries. Its common stock is a constituent of the S&P 500 and trades on the New York Stock Exchange. Invesco operates under the Invesco, Invesco Perpetual, and Powershares brand names.

Rollins, Inc. is a North American pest control company serving residential and commercial clients. Operating globally through its wholly owned subsidiaries, Orkin, Inc., PCO Services, HomeTeam Pest Defense, Western Pest Services, Industrial Fumigant Company, TruTech, Critter Control, Crane, Waltham, OPC Services, PermaTreat, Northwest Exterminating, McCall Service and Clark Pest Control, as well UK subsidiaries Integrated Pest Management Limited, Safeguard Pest Control, NBC Environment, Europ...

IVZ vs ROL — Head-to-Head

Bigger by revenue
IVZ
IVZ
1.9× larger
IVZ
$1.7B
$906.4M
ROL
Growing faster (revenue YoY)
ROL
ROL
+4.0% gap
ROL
10.2%
6.2%
IVZ
Higher net margin
ROL
ROL
70.8% more per $
ROL
11.9%
-58.9%
IVZ
More free cash flow
IVZ
IVZ
$321.0M more FCF
IVZ
$432.2M
$111.2M
ROL
Faster 2-yr revenue CAGR
IVZ
IVZ
Annualised
IVZ
7.1%
0.8%
ROL

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
IVZ
IVZ
ROL
ROL
Revenue
$1.7B
$906.4M
Net Profit
$-995.9M
$107.8M
Gross Margin
Operating Margin
-86.2%
16.1%
Net Margin
-58.9%
11.9%
Revenue YoY
6.2%
10.2%
Net Profit YoY
-575.8%
2.5%
EPS (diluted)
$-2.61
$0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IVZ
IVZ
ROL
ROL
Q1 26
$906.4M
Q4 25
$1.7B
$912.9M
Q3 25
$1.6B
$1.0B
Q2 25
$1.5B
$999.5M
Q1 25
$1.5B
$822.5M
Q4 24
$1.6B
$832.2M
Q3 24
$1.5B
$916.3M
Q2 24
$1.5B
$891.9M
Net Profit
IVZ
IVZ
ROL
ROL
Q1 26
$107.8M
Q4 25
$-995.9M
$116.4M
Q3 25
$356.4M
$163.5M
Q2 25
$197.4M
$141.5M
Q1 25
$171.1M
$105.2M
Q4 24
$209.3M
$105.7M
Q3 24
$55.0M
$136.9M
Q2 24
$132.2M
$129.4M
Operating Margin
IVZ
IVZ
ROL
ROL
Q1 26
16.1%
Q4 25
-86.2%
17.5%
Q3 25
16.5%
21.9%
Q2 25
14.1%
19.8%
Q1 25
18.1%
17.3%
Q4 24
19.6%
18.1%
Q3 24
6.6%
20.9%
Q2 24
13.9%
20.4%
Net Margin
IVZ
IVZ
ROL
ROL
Q1 26
11.9%
Q4 25
-58.9%
12.8%
Q3 25
21.7%
15.9%
Q2 25
13.0%
14.2%
Q1 25
11.2%
12.8%
Q4 24
13.1%
12.7%
Q3 24
3.6%
14.9%
Q2 24
8.9%
14.5%
EPS (diluted)
IVZ
IVZ
ROL
ROL
Q1 26
$0.22
Q4 25
$-2.61
$0.24
Q3 25
$0.66
$0.34
Q2 25
$-0.03
$0.29
Q1 25
$0.38
$0.22
Q4 24
$0.46
$0.22
Q3 24
$0.12
$0.28
Q2 24
$0.29
$0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IVZ
IVZ
ROL
ROL
Cash + ST InvestmentsLiquidity on hand
$1.0B
$116.5M
Total DebtLower is stronger
$1.8B
$650.6M
Stockholders' EquityBook value
$12.2B
$1.4B
Total Assets
$27.1B
$3.2B
Debt / EquityLower = less leverage
0.15×
0.47×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IVZ
IVZ
ROL
ROL
Q1 26
$116.5M
Q4 25
$1.0B
$100.0M
Q3 25
$973.1M
$127.4M
Q2 25
$922.7M
$123.0M
Q1 25
$821.7M
$201.2M
Q4 24
$986.5M
$89.6M
Q3 24
$1.0B
$95.3M
Q2 24
$878.5M
$106.7M
Total Debt
IVZ
IVZ
ROL
ROL
Q1 26
$650.6M
Q4 25
$1.8B
$486.1M
Q3 25
$1.6B
$485.7M
Q2 25
$1.9B
$485.3M
Q1 25
$964.8M
$485.5M
Q4 24
$890.6M
$395.3M
Q3 24
$890.3M
Q2 24
$890.1M
Stockholders' Equity
IVZ
IVZ
ROL
ROL
Q1 26
$1.4B
Q4 25
$12.2B
$1.4B
Q3 25
$14.0B
$1.5B
Q2 25
$13.9B
$1.4B
Q1 25
$14.7B
$1.4B
Q4 24
$14.6B
$1.3B
Q3 24
$14.8B
$1.3B
Q2 24
$14.6B
$1.2B
Total Assets
IVZ
IVZ
ROL
ROL
Q1 26
$3.2B
Q4 25
$27.1B
$3.1B
Q3 25
$28.4B
$3.2B
Q2 25
$28.5B
$3.2B
Q1 25
$28.1B
$2.9B
Q4 24
$27.0B
$2.8B
Q3 24
$27.5B
$2.8B
Q2 24
$27.2B
$2.8B
Debt / Equity
IVZ
IVZ
ROL
ROL
Q1 26
0.47×
Q4 25
0.15×
0.35×
Q3 25
0.12×
0.32×
Q2 25
0.14×
0.34×
Q1 25
0.07×
0.36×
Q4 24
0.06×
0.30×
Q3 24
0.06×
Q2 24
0.06×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IVZ
IVZ
ROL
ROL
Operating Cash FlowLast quarter
$455.8M
$118.4M
Free Cash FlowOCF − Capex
$432.2M
$111.2M
FCF MarginFCF / Revenue
25.5%
12.3%
Capex IntensityCapex / Revenue
1.4%
0.8%
Cash ConversionOCF / Net Profit
1.10×
TTM Free Cash FlowTrailing 4 quarters
$1.4B
$621.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IVZ
IVZ
ROL
ROL
Q1 26
$118.4M
Q4 25
$455.8M
$164.7M
Q3 25
$606.2M
$191.3M
Q2 25
$547.9M
$175.1M
Q1 25
$-84.6M
$146.9M
Q4 24
$316.9M
$188.2M
Q3 24
$438.4M
$146.9M
Q2 24
$489.1M
$145.1M
Free Cash Flow
IVZ
IVZ
ROL
ROL
Q1 26
$111.2M
Q4 25
$432.2M
$159.0M
Q3 25
$586.4M
$182.8M
Q2 25
$530.4M
$168.0M
Q1 25
$-108.0M
$140.1M
Q4 24
$309.9M
$184.0M
Q3 24
$410.0M
$139.4M
Q2 24
$462.4M
$136.4M
FCF Margin
IVZ
IVZ
ROL
ROL
Q1 26
12.3%
Q4 25
25.5%
17.4%
Q3 25
35.7%
17.8%
Q2 25
35.0%
16.8%
Q1 25
-7.1%
17.0%
Q4 24
19.5%
22.1%
Q3 24
27.1%
15.2%
Q2 24
31.2%
15.3%
Capex Intensity
IVZ
IVZ
ROL
ROL
Q1 26
0.8%
Q4 25
1.4%
0.6%
Q3 25
1.2%
0.8%
Q2 25
1.2%
0.7%
Q1 25
1.5%
0.8%
Q4 24
0.4%
0.5%
Q3 24
1.9%
0.8%
Q2 24
1.8%
1.0%
Cash Conversion
IVZ
IVZ
ROL
ROL
Q1 26
1.10×
Q4 25
1.41×
Q3 25
1.70×
1.17×
Q2 25
2.78×
1.24×
Q1 25
-0.49×
1.40×
Q4 24
1.51×
1.78×
Q3 24
7.97×
1.07×
Q2 24
3.70×
1.12×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IVZ
IVZ

Investment Advice$1.2B73%
Distribution And Shareholder Service$382.7M23%
Financial Service Other$51.0M3%
Investment Performance$28.9M2%

ROL
ROL

Segment breakdown not available.

Related Comparisons